These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 30852731)
21. Chemogenetic Regulation of CX3CR1-Expressing Microglia Using Gi-DREADD Exerts Sex-Dependent Anti-Allodynic Effects in Mouse Models of Neuropathic Pain. Saika F; Matsuzaki S; Kobayashi D; Ideguchi Y; Nakamura TY; Kishioka S; Kiguchi N Front Pharmacol; 2020; 11():925. PubMed ID: 32636748 [TBL] [Abstract][Full Text] [Related]
22. Lipopolysaccharide-induced maternal immune activation modulates microglial CX3CR1 protein expression and morphological phenotype in the hippocampus and dentate gyrus, resulting in cognitive inflexibility during late adolescence. Fernández de Cossío L; Lacabanne C; Bordeleau M; Castino G; Kyriakakis P; Tremblay MÈ Brain Behav Immun; 2021 Oct; 97():440-454. PubMed ID: 34343619 [TBL] [Abstract][Full Text] [Related]
23. Colony-stimulating factor 1 receptor inhibition prevents disruption of the blood-retina barrier during chronic inflammation. Kokona D; Ebneter A; Escher P; Zinkernagel MS J Neuroinflammation; 2018 Dec; 15(1):340. PubMed ID: 30541565 [TBL] [Abstract][Full Text] [Related]
24. CX3CR1-microglia mediates neuroinflammation and blood pressure regulation in the nucleus tractus solitarii of fructose-induced hypertensive rats. Ho CY; Lin YT; Chen HH; Ho WY; Sun GC; Hsiao M; Lu PJ; Cheng PW; Tseng CJ J Neuroinflammation; 2020 Jun; 17(1):185. PubMed ID: 32532282 [TBL] [Abstract][Full Text] [Related]
25. A Novel Mechanism of BAM8-22 Inhibiting Microglia Activation: Represses CX3CR1 Expression via Upregulating miR-184. Wang A; Tie M; Guo D; Wu N; Yao S; Yan L; Zhao X J Mol Neurosci; 2020 Apr; 70(4):550-558. PubMed ID: 31833017 [TBL] [Abstract][Full Text] [Related]
26. Protective effects of Garcinol against neuropathic pain - Evidence from in vivo and in vitro studies. Wang YW; Zhang X; Chen CL; Liu QZ; Xu JW; Qian QQ; Li WY; Qian YN Neurosci Lett; 2017 Apr; 647():85-90. PubMed ID: 28302538 [TBL] [Abstract][Full Text] [Related]
27. Up-regulated fractalkine (FKN) and its receptor CX3CR1 are involved in fructose-induced neuroinflammation: Suppression by curcumin. Xu MX; Yu R; Shao LF; Zhang YX; Ge CX; Liu XM; Wu WY; Li JM; Kong LD Brain Behav Immun; 2016 Nov; 58():69-81. PubMed ID: 26765996 [TBL] [Abstract][Full Text] [Related]
29. Paclitaxel-induced neuropathic pain is age dependent and devolves on glial response. Ruiz-Medina J; Baulies A; Bura SA; Valverde O Eur J Pain; 2013 Jan; 17(1):75-85. PubMed ID: 22623135 [TBL] [Abstract][Full Text] [Related]
30. Characterisation of Immune and Neuroinflammatory Changes Associated with Chemotherapy-Induced Peripheral Neuropathy. Makker PG; Duffy SS; Lees JG; Perera CJ; Tonkin RS; Butovsky O; Park SB; Goldstein D; Moalem-Taylor G PLoS One; 2017; 12(1):e0170814. PubMed ID: 28125674 [TBL] [Abstract][Full Text] [Related]
31. miR-451 elevation relieves inflammatory pain by suppressing microglial activation-evoked inflammatory response via targeting TLR4. Sun X; Zhang H Cell Tissue Res; 2018 Dec; 374(3):487-495. PubMed ID: 30069596 [TBL] [Abstract][Full Text] [Related]
32. Early-Released Interleukin-10 Significantly Inhibits Lipopolysaccharide-Elicited Neuroinflammation In Vitro. Wang Y; Yu P; Li Y; Zhao Z; Wu X; Zhang L; Feng J; Hong JS Cells; 2021 Aug; 10(9):. PubMed ID: 34571824 [TBL] [Abstract][Full Text] [Related]
33. Targeting macrophage and microglia activation with colony stimulating factor 1 receptor inhibitor is an effective strategy to treat injury-triggered neuropathic pain. Lee S; Shi XQ; Fan A; West B; Zhang J Mol Pain; 2018; 14():1744806918764979. PubMed ID: 29546785 [TBL] [Abstract][Full Text] [Related]
34. GPR34 in spinal microglia exacerbates neuropathic pain in mice. Sayo A; Konishi H; Kobayashi M; Kano K; Kobayashi H; Hibi H; Aoki J; Kiyama H J Neuroinflammation; 2019 Apr; 16(1):82. PubMed ID: 30975169 [TBL] [Abstract][Full Text] [Related]
35. Z-guggulsterone negatively controls microglia-mediated neuroinflammation via blocking IκB-α-NF-κB signals. Huang C; Wang J; Lu X; Hu W; Wu F; Jiang B; Ling Y; Yang R; Zhang W Neurosci Lett; 2016 Apr; 619():34-42. PubMed ID: 26879835 [TBL] [Abstract][Full Text] [Related]
36. Role of interleukin-4, the chemokine CCL3 and its receptor CCR5 in neuropathic pain. Sun S; Chen D; Lin F; Chen M; Yu H; Hou L; Li C Mol Immunol; 2016 Sep; 77():184-92. PubMed ID: 27522478 [TBL] [Abstract][Full Text] [Related]
37. The induction of neuronal death by up-regulated microglial cathepsin H in LPS-induced neuroinflammation. Fan K; Li D; Zhang Y; Han C; Liang J; Hou C; Xiao H; Ikenaka K; Ma J J Neuroinflammation; 2015 Mar; 12():54. PubMed ID: 25889123 [TBL] [Abstract][Full Text] [Related]
38. Spinal interleukin-10 produces antinociception in neuropathy through microglial β-endorphin expression, separated from antineuroinflammation. Wu HY; Mao XF; Tang XQ; Ali U; Apryani E; Liu H; Li XY; Wang YX Brain Behav Immun; 2018 Oct; 73():504-519. PubMed ID: 29928964 [TBL] [Abstract][Full Text] [Related]
39. AMPK activation attenuates inflammatory pain through inhibiting NF-κB activation and IL-1β expression. Xiang HC; Lin LX; Hu XF; Zhu H; Li HP; Zhang RY; Hu L; Liu WT; Zhao YL; Shu Y; Pan HL; Li M J Neuroinflammation; 2019 Feb; 16(1):34. PubMed ID: 30755236 [TBL] [Abstract][Full Text] [Related]
40. Inhibitory effects of ginsenoside Rb1 on neuroinflammation following systemic lipopolysaccharide treatment in mice. Lee JS; Song JH; Sohn NW; Shin JW Phytother Res; 2013 Sep; 27(9):1270-6. PubMed ID: 23042638 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]